Search Tag: nucleosomics technology

Executive Health Management

VolitionRx and University Hospital Bonn Collaborate on Cancer Diagnostic Test Evaluation

2014 25 Apr

The agreement includes CE Mark performance evaluation and doubles the Hospital’s prospective trial of 20 cancers, adding a range of additional vital background work   VolitionRx Limited, a life sciences company focused on developing blood-based diagnostic tests for different types of cancer, has announced that VolitionRx has extended its agreement... Read more